PO:27:108 | Delphi consensus on the shared management of patients with rheumatologic and oncologic diseases
Background. The intersection between rheumatologic and oncologic diseases, especially concerning the use of immunostimulatory cancer therapies, poses relevant clinical challenges. Immunotherapy may induce rheumatologic or autoimmune manifestations, while csDMARDs or bDMARDs can affect the efficacy...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
PAGEPress Publications
2025-11-01
|
| Collection: | Reumatismo |
| Sujets: | |
| Accès en ligne: | https://www.reumatismo.org/reuma/article/view/2195 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|